BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20150329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20151025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170505
DTEND;VALUE=DATE:20170606
DTSTAMP:20170511T113443Z
CREATED:20170505T162515Z
LAST-MODIFIED:20170511T113443Z
UID:17829-1493942400-1496707199@ces.b2sg.org
SUMMARY:Postdoctoral Fellow- Oncology
DESCRIPTION:We seek a driven and accomplished postdoctoral fellow to join the cancer epigenetics group within the Oncology R&D (ORD) unit of Pfizer’s Worldwide R&D (WRD) division in La Jolla\, California. The successful candidate will collaborate with our cancer-immunopharmacology group to study the roles of epigenetic enzymes in anti-tumor immune responses. Guided by experienced mentors with strong academic track records\, the successful candidate will study fundamental questions in cancer immunology with the ultimate goal of publication in major scientific journals. Thus\, a strong scientific background with relevant expertise and documented accomplishments including significant publications is required. In addition\, the successful candidate will have a strong interest in translating results into novel immunotherapies for cancer. He/she will be highly self-motivated with a sense of urgency and focus on important problems. While driven to make strong individual contributions\, the successful candidate will also enjoy a highly interactive\, team-oriented environment and thrive by taking advantage of the significant multi-disciplinary resources available at Pfizer. This will be facilitated by the candidate’s excellent communication and interpersonal skills\, which complement strong work ethics and overall scientific excellence. \nResponsibilities \nPrimary Duties: \n\nWork independently and as part of teams to conceive\, design\, execute\, analyze/interpret\, and refine experiments ranging from biochemical and molecular assays\, in vitro and in vivo immunological functional assays in model systems\, and clinical sample analysis. Specific duties to include:\nContribute intellectually and at the bench to the conception\, design\, execution\, analysis\, interpretation and internal or external presentation of studies of epigenetic modulators of the anti-tumor immune response.\nKeep abreast with the literature and internal developments to become an expert point of contact for colleagues in the field of epigenetic immunopharmacology\nIndependently\, but with guidance by experienced mentors\, develop results into compelling stories for publication in major scientific journals and presentations on major scientific meetings and conferences\, both internally and externally\nApply genetic and pharmacologic approaches to modulate targets in vitro and in vivo to assess functional impacts on tumor cells and immune cells\, and on anti-tumor immune responses in syngeneic xenograft models and genetically engineered mutant mouse models of cancer. This will include CRISPR\, RNAi\, viral vector delivery\, transfection\, antibodies\, small molecules and other pharmacologic approaches to modulate targets.\nExecute secondary assays across various technology platforms – qRT-PCR\, immunoprecipitation\, ChIP-seq\, ATAC-seq\, FACS\, immunofluorescence\, western blotting\, ELISA\, high content screening\, etc.\nDevelop and apply complex in vitro assays for exploring target biology in tumor cells versus immune cells including T-cell functional assays\, co-culture assays\, ect.\nCollaborate with computational biology groups to analyze data including ChIP-seq\, RNA-seq\, ATAC-seq to support mechanism of action studies.\nEmploy computational and proteomic methods for tumor neoantigen prediction and functional validation\nUse electronic data capture/analysis tools such as Excel\, GraphPad\, Biobook\, Spotfire and PowerPoint for experimental documentation and data analysis/presentations.\nPresent research results and methodologies at weekly meetings with immediate supervisor and/or project leader\, and at meetings with members of the oncology research unit as appropriate.\nContribute to building a culture that embraces scientific excellence\, urgency\, partnerships with key stakeholders\, continuous learning and improvement\, increasing technical skill base and cancer biology expertise; take a proactive role in personal growth and scientific development.\n\nQualifications \nEducation and Experience: \n\nPh.D. in Cell Biology\, Molecular Biology\, or Immunology (or a comparable biological science) with a track record of scientific accomplishment as exemplified by significant scientific publications\nExperience with devising and implementing in vitro and in vivo immunological functional assays\nExperience in immuno-oncology and/or chromatin biology/epigenetics is desirable\nExperience in nucleic acid and protein extraction techniques and downstream analyses including quantitative RT-PCR\, immunoprecipitation (including ChIP)\, and immunoblotting.\nExperience with computational tools for antigen prediction\, NGS experiment design and data analyses\, including epigenomic data\, is desired\nAbility to work in a team environment; excellent written and oral communication skills in English; strong presentation skills and ability to discuss data at project team meetings.\nAble to master new concepts and techniques quickly.\nStrong attention to detail and organizational skills to manage projects in parallel\n\nPHYSICAL/MENTAL REQUIREMENTS: \nLifting\, sitting\, standing\, walking\, bending\, ability to perform mathematical calculations\, ability to read\, comprehend and process complex scientific matter\, and perform complex data analysis. Ability to travel by air\, water and ground. \nNON-STANDARD WORK SCHEDULE\, TRAVEL OR ENVIRONMENT REQUIREMENTS: \nAbility to accommodate non-standard work schedules due to experimental regimen or travel. Ability to adhere to safe work practices and wear full personal protective equipment. Ability to travel nationally and internationally. \nA career at Pfizer offers opportunity\, ownership and impact. All over the world\, Pfizer colleagues work together to positively impact health for everyone\, everywhere. Our colleagues have the opportunity to grow and develop a career that offers both individual and company success; be part of an ownership culture that values diversity and where all colleagues are energized and engaged; and the ability to impact the health and lives of millions of people. Pfizer\, a global leader in the biopharmaceutical industry\, is continuously seeking top talent who are inspired by our purpose to innovate to bring therapies to patients that significantly improve their lives. \nPfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race\, color\, religion\, sex\, sexual orientation\, age\, gender identity or gender expression\, national origin\, disability or veteran status. Pfizer also complies with all applicable national\, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
URL:https://ces.b2sg.org/event/postdoc-oncology-pfizer/
LOCATION:Pfizer – La Jolla\, CA\, 10350 N Torrey Pines Rd\, La Jolla\, CA\, 92037\, United States
CATEGORIES:Jobs
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170505
DTEND;VALUE=DATE:20170606
DTSTAMP:20170505T165245Z
CREATED:20170505T123927Z
LAST-MODIFIED:20170505T165245Z
UID:17828-1493942400-1496707199@ces.b2sg.org
SUMMARY:Research Associate II – Leukemia Lab
DESCRIPTION:A Research Associate II position is available in the Leukemia Research Laboratory of Gehr Family Center for Leukemia Research and the Beckman Research Institute of City of Hope. \nThe Center is supported by outstanding core facilities including\, but not limited to\, a large human and mouse leukemia tissue bank\, and GMP facilities for new drug development and exceptional Sequencing and Bioinformatics services. Our long-term goal is to elucidate the mechanisms of leukemogenesis and drug resistance of primitive leukemia cells\, and to identify novel therapeutic approaches in blood cancers. Our current research efforts are directed towards understanding the molecular and cellular pathways underlying the pathogenesis of acute myeloid leukemia (AML) using a combination of genetics\, genomics\, biochemistry\, proteomics\, molecular biology and cellular biology approaches. Our experimental systems include both genetic mouse models and primary leukemia stem cells from AML patients. The focus of this position is to understand the role of epigenetic changes in leukemia development\, progression and maintenance. \nPlease include a cover letter stating research interests and experiences\, curriculum vitae\, and names and contact information of three references. \nMinimum Education and Skills Required for Consideration: \n\nBachelor’s degree in biomedical related fields plus two years related research/laboratory experience.\nMaster’s degree in biomedical related fields preferred plus one year related research/laboratory experience preferred.\nMust be highly motivated with excellent organization and communication skills.\nCandidates with skills in molecular biology\, biochemistry\, tissue culture\, flow cytometry\, gene transfer\, mouse handling and transplantation techniques are preferred.\n\nAbout City of Hope \nCity of Hope\, an innovative biomedical research\, treatment and educational institution with over 4000 employees\, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate\, patient-centered philosophy. Founded in 1913 and headquartered in Duarte\, California\, City of Hope is a remarkable non-profit institution\, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network\, an alliance of the nation’s 20 leading cancer centers that develops and institutes standards of care for cancer treatment. \nCity of Hope is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race\, religion\, color\, national origin\, sex\, sexual orientation\, gender identity\, age\, status as a protected veteran\, or status as a qualified individual with disability.
URL:https://ces.b2sg.org/event/research-associate-ii-leukemia-lab/
LOCATION:Beckman Research Institute\, 1500 E Duarte Rd.\, Duarte\, CA\, 91741\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/02/City-of-hope.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170504
DTEND;VALUE=DATE:20170605
DTSTAMP:20170504T222701Z
CREATED:20170504T222327Z
LAST-MODIFIED:20170504T222701Z
UID:17825-1493856000-1496620799@ces.b2sg.org
SUMMARY:Senior Scientific Researcher - Molecular Biology
DESCRIPTION:The Position\nWe are seeking a Senior Scientific Researcher in the Department of Molecular Biology to assist with the development of an advanced cell-based molecular genetics platform. She/he will utilize and create diverse nucleic-acid-based technologies for targeted manipulation of primary and immortalized cells\, with the ultimate goal of improving upon in vitro disease models and approaches for scalable functional genomic screening. The candidate will be expected to work creatively and independently within a dynamic\, highly collaborative research environment. \nWho You Are\nA self-motivated candidate with a PhD in Genetics\, Molecular Biology\, Biochemistry\, Cancer Biology\, or a related discipline. Qualified candidates will have a skillset demonstrating successful application of gene expression analyses and genetic manipulation either in cell-based systems or model organisms. Preferred expertise includes some or all of the following: molecular cloning\, RNA/DNA/protein quantification\, 2D and 3D cell culture\, primary and/or stem cell models\, genome engineering\, epigenetics\, and viral vector development/use. Working knowledge of pooled vector-based screening\, Next-Gen Sequencing (NGS)\, biostatistics\, and/or basic bioinformatics is strongly desired. The successful candidate will be highly organized\, and have excellent communication skills\, both written and verbal. \nWho We Are\nA member of the Roche Group\, Genentech has been at the forefront of the biotechnology industry for more than 40 years\, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech has multiple therapies on the market for cancer & other serious illnesses. Please take this opportunity to learn about Genentech where we believe that our employees are our most important asset & are dedicated to remaining a great place to work. \nThe next step is yours. To apply today\, click on the “Apply online” button. \nGenentech is an equal opportunity employer & prohibits unlawful discrimination based on race\, color\, religion\, gender\, sexual orientation\, gender identity/expression\, national origin/ancestry\, age\, disability\, marital & veteran status. For more information about equal employment opportunity\, visit our Genentech Careers page.
URL:https://ces.b2sg.org/event/sen-researcher-mol-bio-genentech/
LOCATION:Genentech\, 1 DNA Way\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/genentech-logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170504
DTEND;VALUE=DATE:20170605
DTSTAMP:20170505T165403Z
CREATED:20170504T220124Z
LAST-MODIFIED:20170505T165403Z
UID:17822-1493856000-1496620799@ces.b2sg.org
SUMMARY:Postdoc Position - Investigator\, Medicinal Chemistry
DESCRIPTION:Basic qualifications: \n • PhD degree in Organic Chemistry\, or Medicinal Chemistry.\n• 0 to 3 years of professional and/or industrial experience.\n• High level of synthetic chemistry expertise allowing one to plan synthetic routes to\, and prepare molecules of interest to advance lead optimization efforts.\n• Well versed in the application of new synthetic methodology.\n• High level of scientific credibility as demonstrated through peer-reviewed publications\, presentations\, or patents. \nPreferred qualifications: \n • Post-doc\n• Demonstrated autonomy in decision making.\n• Ability to excel in a team environment and work efficiently in an open-plan laboratory.\n• Excellent written and oral communication skills. \nDetails: \n The successful applicant will join a highly motivated medicinal chemistry team within Oncology Research & Development where the focus will be on progressing hit series through to candidate selection against Epigenetic targets.  The successful applicant will have opportunities to design and implement insightful and creative medicinal chemistry strategies to fulfill these objectives. The applicant will be expected to develop a deep expertise in lead optimization tactics including state-of-the-art synthesis\, purification\, and computational tools. \nPlease note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license\, GSK may be required to capture and report expenses GSK incurs\, on your behalf\, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information\, please visit GSK’s Transparency Reporting For the Record site.
URL:https://ces.b2sg.org/event/postdoc-med-chem-gsk/
LOCATION:gsk\, 1250 S Collegeville Rd\, Collegeville\, PA\, 19426\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/GSK.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170504
DTEND;VALUE=DATE:20170605
DTSTAMP:20170505T165446Z
CREATED:20170504T134233Z
LAST-MODIFIED:20170505T165446Z
UID:17817-1493856000-1496620799@ces.b2sg.org
SUMMARY:Research Associate - Epigenetics
DESCRIPTION:To enable Guardant Health to lead the disruption of cancer treatments through non-invasive cancer screening\, the Technology Development Team is seeking a highly motivated Research Associate to help develop\, test\, and improve sample preparation technologies for rare variant and epigenetic studies with next-generation sequencing. At Guardant\, we leverage the most advanced technologies and work with leaders in many different fields to create the most impactful and meaningful technologies for cancer management. \nAs a Research Associate supporting product and technology development\, you will work with members within the team and interface with multiple teams including process engineering\, clinical operations\, research operations\, and bioinformatics. You will be hands on in the lab and be required to design\, implement\, and validate new technologies related to liquid biopsy sequencing assays for the early detection\, treatment\, and monitoring of all cancer types. \nRESPONSIBILITIES \n\nOperate next generation sequencing instruments\nRun sequencing sample preparation assays in medium to high throughput environment\nTest and improve new sequencing sample preparation assays\nLog and track research samples throughout sequencing workflow\nMaintain appropriate inventory of lab supplies\nBring a can do attitude to solve new and challenging problems in a high pace environment\nAnalyze data and troubleshoot issues within the tech dev team and among other teams\nCollaborate with all functions within project teams\nEngage in early design of products and perform experiments both independently and under the supervision of Senior team members within Tech Dev and Bioinformatics groups\nBe able to present updates\, write reports and SOPs\, and contribute to technical discussions\n\nABOUT YOU \n\nThe ability to handle biological samples (i.e. tissue\, biofluid\, etc.) is a must\nExcellent written and oral communication skills is a must\nProfessional hands-on experience in industrial setting in genomics field is a plus (operational experience is preferred)\nHands-on experience in running sequencing platforms and assays is a plus\n\nGuardant Health develops breakthrough diagnostic technologies to improve cancer management. With Guardant360\, we offer real-time\, biopsy-free tumor sequencing that tracks tumor genomics in real-time and identifies associated treatment options. The recent introduction of groundbreaking analytical tools\, including our Tumor Response Map and a mobile-enabled physician portal\, further advance Guardant Health’s momentum. \nGuardant Health has raised almost $200M from OrbiMed\, Sequoia Capital\, Khosla Ventures\, Lightspeed Venture Partners\, and Formation8\, and is led by a seasoned management team of thought leaders and successful serial entrepreneurs in next generation sequencing and rare cell diagnostics. They are advised by an oncologist-led medical steering committee from leading cancer centers.
URL:https://ces.b2sg.org/event/research-associate-epigenetics-gh/
LOCATION:Guardant Health\, 505 Penobscot Dr.\, Redwood City\, CA\, 94063\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/guardant-health.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170503
DTEND;VALUE=DATE:20170604
DTSTAMP:20170505T170239Z
CREATED:20170503T134135Z
LAST-MODIFIED:20170505T170239Z
UID:17789-1493769600-1496534399@ces.b2sg.org
SUMMARY:Postdoctoral Fellow - Molecular Oncology
DESCRIPTION:A postdoctoral position is available in the laboratory of Dr. Florian Karreth at the Moffitt Cancer Center. The Karreth lab combines innovative mouse modeling approaches with molecular biology and biochemistry techniques to better understand the crosstalk between oncogenic signaling and non-coding RNAs in the development\, progression\, and resistance of cancer. \nWe are particularly interested in identifying and characterizing protein-coding and non-coding genes that cooperate with oncogenic MAPK signaling to promote tumor progression and drug resistance\, with an emphasis on melanoma. Moreover\, we are studying the oncogenic functions of lncRNAs in ovarian cancer. For more information visit our lab website at http://labpages2.moffitt.org/karreth. \nWe seek a talented and dedicated individual with an interest in characterizing proteins that promote the progression and drug resistance of melanoma.   \nCandidates must demonstrate excellent communication skills\, have a proven track record of scientific productivity\, and be able to work collaboratively in a team.   Experience in mouse modeling and/or oncogenic signaling is highly desirable.   We also seek a talented and dedicated individual with an interest in understanding how ovarian cancer risk SNPs affect lncRNAs expression and function. \nSuccessful candidates will work independently and collaboratively\, design and execute experiments\, and analyze and interpret data. He/She will present his/her findings to the lab during weekly lab meetings\, to the Moffitt community at research-in-progress meetings\, and to the international community at conferences. He/She will author grants and manuscripts\, and mentor students. \nPh.D. or M.D.\, preferably not received more than two years ago. \nThe outstanding research environment includes a new dedicated research building\, state-of-the-art core facilities (e.g. Molecular Genomics\, Flow Cytometry\, Proteomics\, Microscopy\, Transgenic)\, a modern vivarium\, and access to clinical material. A competitive salary and benefits package will be offered to the successful candidate. Interested applicants should email a letter describing their interest and previous experience as well as a CV including the names and contact information of three references to florian.karreth@moffitt.org. \nThe H. Lee Moffitt Cancer and Research Institute is a modern facility in Tampa\, Florida.  We strive to be the leader in understanding in the complexity of cancer through team science and applying those insights for human benefits.  Be part of the cure by joining Moffitt’s team of 800 research faculty scientists\, career staff scientists\, postdocs\, graduate students and support staff dedicated to cancer research. \n 
URL:https://ces.b2sg.org/event/postdoc-molecular-oncology/
LOCATION:Moffitt Cancer Center Magnolia Campus\, 12902 USF Magnolia Drive\, Tampa\, FL\, 33612\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/Moffitt-1.jpg
ORGANIZER;CN="Florian Karreth":MAILTO: florian.karreth@moffitt.org.
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170503
DTEND;VALUE=DATE:20170604
DTSTAMP:20170505T170129Z
CREATED:20170503T131626Z
LAST-MODIFIED:20170505T170129Z
UID:17783-1493769600-1496534399@ces.b2sg.org
SUMMARY:Postdoctoral Researcher – Structural Biology
DESCRIPTION:The laboratory of Dr. Ernst Schonbrunn at Moffitt Cancer Center is seeking a postdoctoral researcher to work on inter-disciplinary projects towards the structural biology of proteins as drug targets. The position provides exciting opportunities for structural\, biochemical and cell-based studies of various drug-target interactions and the rational design of new inhibitors with potential as therapeutics. We work in team with medicinal chemists\, biologists and clinicians on the targeting of proteins involved in signaling and epigenetic events. \nThe successful candidate is a highly motivated individual with a PhD or equivalent degree in Biochemistry\, Chemistry or related field. Demonstrated expertise in protein crystallography and biochemical/biophysical characterization of proteins is required.  Candidates must be enthusiastic with excellent organizational skills and effective at working independently\, while also collaborating and assisting the team in its collective research goals. Attention to detail and ability to work on multiple projects is required. Excellent verbal and written communication skills are required.  \nThe Moffitt Cancer Center is a modern research facility on the University of South Florida Campus that conducts research on various aspects of Cancer Biology. The research environment includes state of the art core facilities to support basic research. Please apply online at www.moffitt.org/careers to REQ ID 21506 and send cover letter\, CV and the names and contact information of three references via email to ernst.schonbrunn@moffitt.org. \nMoffitt Cancer Center is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race\, color\, religion\, sex\, sexual orientation\, gender identity\, national origin\, age\, or protected veteran or disabled status. We seek candidates whose skills\, and personal and professional experience\, have prepared them to contribute to our commitment to diversity and excellence.  \n 
URL:https://ces.b2sg.org/event/postdoc-researcher-structural-bio/
LOCATION:Moffitt Cancer Center Magnolia Campus\, 12902 USF Magnolia Drive\, Tampa\, FL\, 33612\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/Moffitt-1.jpg
ORGANIZER;CN="Ernst Schonbrunn":MAILTO:ernst.schonbrunn@moffitt.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170503
DTEND;VALUE=DATE:20170604
DTSTAMP:20170505T165812Z
CREATED:20170502T235227Z
LAST-MODIFIED:20170505T165812Z
UID:17780-1493769600-1496534399@ces.b2sg.org
SUMMARY:Postdoctoral Positions - Gene Regulation\, Epigenetics and/or Cancer Biology
DESCRIPTION:Postdoctoral associate positions available for highly motivated candidates with a fresh PHD training in molecular & cell biology\, cancer biology and/or biochemistry to join the Lineberger Comprehensive Cancer Center\, the Department of Biochemistry & Biophysics\, University of North Carolina at Chapel Hill (UNC) School of Medicine\, USA. Those with a strong publication track record are also potentially eligible for a two-year postdoctoral fellowship program available from UNC Cancer Center Postdoc Trainee programs (eligibility: 1\, within less than 1-2 years since completion of PHD training; 2\, US citizen or permanent resident). \nOur laboratory emphasizes on mechanistic understandings of gene regulation\, chromatin biology\, stem cells\, and human disease\, notably cancer (see our recent publications at Molecular Cell 2013\, Blood 2015\, Cell Reports 2015; Cancer Cell 2016). Multiple on-going projects include (1) biochemical characterization of novel factors/complexes that recognize the novel chromatin modifications; (2) CRISPR/dCas9-based editing of epigenomic modifications for understanding the epigenetic pathways in gene expression; (3) knockout and knock-in mouse models with deficiency in histone methylation regulation in context of development and tumorigenesis\, with a special focus on hematopoietic cancer and disease; (4) epigenomic and transcriptome analyses (ChIP-Seq and RNA-Seq) of normal versus cancer cells to delineate pathways essential for tumor growth. \nThe salary of postdoc positions meets new federal Fair Labor Standards Act (FLSA) with a minimum salary of $47\,476 annually. Applicants should be self-motivated with a track record of publication in the above area\, have laboratory and analytical skills\, and be a critical thinker. Application shall include CV\, a cover letter (with summary of research experiences and future interests\, and expected availability date) reprints of publications\, and contact information of three references. The application materials should be sent to gregwang.unc@gmail.com. \nThe University of North Carolina at Chapel Hill is an equal opportunity and affirmative action employer.
URL:https://ces.b2sg.org/event/postdoc-epigenetics-cancer-bio/
LOCATION:University of North Carolina – UNC-Chapel Hill\, Chapel Hill\, NC\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/U_North_Carolina-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170502
DTEND;VALUE=DATE:20170603
DTSTAMP:20170505T165918Z
CREATED:20170502T230455Z
LAST-MODIFIED:20170505T165918Z
UID:17775-1493683200-1496447999@ces.b2sg.org
SUMMARY:Postdoctoral Research Fellow - Cancer Genetics and Epigenetics
DESCRIPTION:A postdoctoral position is available in the lab of David MacPherson. The position will be funded by a newly awarded R01\, with a focus on the role of key chromatin regulators in driving small cell lung cancer (SCLC)\, an aggressive neuroendocrine tumor type. Cell based screens\, genetic mouse models and study of patient derived tumors and xenografts will be employed in the research project.  The position is ideally suited to candidates interested in understanding at a molecular level how perturbation of chromatin regulators promotes SCLC and also how mutations in chromatin regulators confer vulnerabilities that can be exploited in the design of more effective therapeutics for SCLC. \n\n\n\n\n\n\nCandidates should have a PhD and/or MD\, one or more first author publications\, and experience in molecular and/or cell biology.  Expertise in chromatin biology\, genomic analyses\, mouse genetics\, and/or experience with cell based functional screens would all be looked upon favorably.  Candidates should be independent but also highly collaborative. \n\nAt Fred Hutchinson Cancer Research Center\, home to three Nobel laureates\, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent\, diagnose and treat cancer\, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy\, which harnesses the power of the immune system to treat cancer. An independent\, nonprofit research institute based in Seattle\, Fred Hutch houses the nation’s first and largest cancer prevention research program\, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.
URL:https://ces.b2sg.org/event/postdoc-fred-hutch/
LOCATION:Fred Hutchinson Cancer Research Center\, 1100 Fairview Ave. N.\, Seattle\, WA\, 98109-1024\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/fred_hutch.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170501
DTEND;VALUE=DATE:20170522
DTSTAMP:20170519T102614Z
CREATED:20170519T004136Z
LAST-MODIFIED:20170519T102614Z
UID:18035-1493596800-1495411199@ces.b2sg.org
SUMMARY:Postdoctoral Fellow
DESCRIPTION:Job Description\nThe Hackett Group is looking for a highly talented postdoctoral researcher to lead an exciting project on epigenetic inheritance in mammalian models. \nResearch in the group is focused on understanding epigenetic mechanisms of genome regulation and transgenerational epigenetic inheritance. Other streams of research cover (epi)genomics analyses of embryonic stem cells and the germline cycle\, and development of epigenetic editing technologies (www.embl.it/research/unit/hackett). \nQualifications and Experience\nYou hold a PhD and have a proven track record in epigenomics\, molecular biology and/or developmental biology\, combined with a strong desire to work on fundamental research questions. Specific experience with epigenetics\, mouse biology or bioinformatics would be a strong plus.  \nThe ideal candidate has strong initiative and ability to independently drive a project forward\, a desire to break new ground with their research\, and is keen to work in a collaborative international environment. \nApplication Instructions\nTo apply please submit a covering letter clearly stating your motivation and future research interests/plans\, and a CV with at least two referees\, through our online system \nwww.embl.org/jobs
URL:https://ces.b2sg.org/event/postdoc-fellow-embl/
LOCATION:EMBL Monterotondo\, Via Ercole Ramarini\, 32\, Monterotondo\, 00015\, Italy
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/embl-logo-e1525286820407.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170306
DTEND;VALUE=DATE:20170308
DTSTAMP:20160908T012217Z
CREATED:20160908T010112Z
LAST-MODIFIED:20160908T012217Z
UID:17388-1488758400-1488931199@ces.b2sg.org
SUMMARY:Epigenetics in Drug Discovery
DESCRIPTION:SELECTBIO is thrilled to announce the continuation of Epigenetics in Drug Discovery for 2017. \nThe event will form part of the multi-track conference\, Advances in Drug Discovery\, and will run alongside three additional tracks: Antibodies in Drug Discovery\, Academic Drug Discovery and Stem Cells in Drug Discovery. \nAs a multi-track event\, delegates will have unrestricted access to all conference tracks and networking opportunities. Attracting researchers from both academia and industry\, this track will explore the latest opportunities and challenges for epigeneticists looking to discover and develop new molecular entities. Topics to be addressed include\, assays for Methyltranferases and Demethylases\, Bromodomain inhibitor discovery\, indications beyond cancer\, Non-BET Bromodomains and of course updates in Oncology. \nThanks to vast steps forwards in this field\, epigenetic compounds are becoming more and more common in both pre-clinical and clinical drug discovery. If you work in epigenetics research\, you will benefit from the expert knowledge of academic and industry leaders who are pushing the boundaries of drug discovery\, whilst networking with the technology providers who are enabling them to do so. \nThe Cancer Epigenetics Society is a Supporting organization for this meeting\, and our members are eligible for a 20% discount on registration fees. Please contact the Cancer Epigenetics Society at info@ces.b2sg.org to claim the discount.
URL:https://ces.b2sg.org/event/epigenetics-in-drug-discovery/
LOCATION:Epigenetics in Drug Discovery\, Wellcome Genome Campus Conference Centre\, Hinxton\, Cambridge\, CB10 1RQ\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/09/SelectBio_logo_greybox_RGB.png
ORGANIZER;CN="SELECTBIO":MAILTO:registrationhelp@selectbio.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170210
DTEND;VALUE=DATE:20170311
DTSTAMP:20170210T232921Z
CREATED:20170210T232735Z
LAST-MODIFIED:20170210T232921Z
UID:17651-1486684800-1489190399@ces.b2sg.org
SUMMARY:Postdoctoral Fellow in Cancer Epigenetics at Beckman Research Institute
DESCRIPTION:Job Title:  Postdoctoral Fellow – Yu Lab \n  \nPosition Summary and Key Responsibilities: \nPostdoctoral positions are available to work in the areas of chromatin remodeling\, epigenetic modifications\, DNA damage response and tumor suppression (Nature 493:561-564; Cancer Cell 23:693-704; Mol. Cell 49:897-907; Genes Dev. 27:1752-1768; Genome Res. 24:570-579). The approaches we take range from mammalian cell culture\, molecular biology\, biochemistry to mouse genetics. A strong background in biochemistry and molecular cell biology is essential. Experience with bioinformatics\, mass spectrometry and mouse model analysis is desirable. We are seeking candidates who are self-motivated and career-oriented. The research environment is outstanding at Beckman Research Institute. Applications should send curriculum vitae\, the names and email addresses of three references to: \n  \nXiaochun Yu\, M.D.\, Ph.D. \nDepartment of Cancer Genetics and Epigenetics \nBeckman Research Institute \nCity of Hope National Medical Center \n1500 E Duarte Rd.\, Duarte\, CA 91741 \nEmail: xyu@coh.org. \n  \nMinimum Education and Skills Required for Consideration: \n• A Ph.D. degree in life or biomedical sciences\, or a related discipline is required. \n  \nAbout City of Hope \nCity of Hope\, an innovative biomedical research\, treatment and educational institution with over 4000 employees\, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate\, patient-centered philosophy. Founded in 1913 and headquartered in Duarte\, California\, City of Hope is a remarkable non-profit institution\, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network\, an alliance of the nation’s 20 leading cancer centers that develops and institutes standards of care for cancer treatment. \nCity of Hope is an equal opportunity employer.  All qualified applicants will receive consideration for employment without regard to race\, religion\, color national origin\, sex\, age\, status as a protected veteran\, or status as a qualified individual with disability.
URL:https://ces.b2sg.org/event/postdoc-bri/
LOCATION:Beckman Research Institute\, 1500 E Duarte Rd.\, Duarte\, CA\, 91741\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/02/City-of-hope.png
ORGANIZER;CN="Department of Cancer Genetics and Epigenetics":MAILTO:xyu@coh.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20161130
DTEND;VALUE=DATE:20161203
DTSTAMP:20160105T223856Z
CREATED:20151230T052431Z
LAST-MODIFIED:20160105T223856Z
UID:12209-1480464000-1480723199@ces.b2sg.org
SUMMARY:4th Max Planck Freiburg Epigenetics Meeting
DESCRIPTION:With the 1st Max Planck Freiburg Epigenetics Meeting in 2010\, we celebrated the establishment of the epigenetic focus at our institute and launched a biennial conference series on epigenetics. \nWe are committed to create an exceptional environment for epigenetic research in Freiburg and we would be very happy if you contributed by sharing your exciting data and novel ideas at the 4th international event which will take place from November 30 to December 2\, 2016. A group of high-profile speakers will be assembled\, representing a broad range of topics in the field of chromatin and epigenetics. We look forward to welcoming you in Freiburg. \nThe programme will include invited and selected talks and give ample time for poster presentations. \nPractical information: \nRegistration will be from 1 April 2016 to 31 August 2016. \nNotification of acceptance for the meeting: 30 September 2016. \nDeadline for payment: 15 October 2016 \nThe conference will take place at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg/Germany\, a medieval city nestled between the famous Black Forest and the vineyards of the Kaiserstuhl.
URL:https://ces.b2sg.org/event/4th-max-planck-freiburg-epigenetics-meeting/
LOCATION:Unnamed Venue\, Freiburg\, Germany
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/MaxPlanck.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20161102
DTEND;VALUE=DATE:20161105
DTSTAMP:20160426T203214Z
CREATED:20160426T201256Z
LAST-MODIFIED:20160426T203214Z
UID:15348-1478044800-1478303999@ces.b2sg.org
SUMMARY:abcam: Stem Cell and Higher-Order Chromatin Structure conference
DESCRIPTION:Present\, learn and collaborate! Present your work and find out the latest news. \nTopics \n\n\n\n\n\n\n\n\n\n\n\n\n\nCoding and non-coding functions of the genome\nChromatin structure in stem cells\nGenome architecture and human disease\n\nDescription \nStem cells have the unique properties of both self renewal and differentiation into various lineages. In the last few years\, chromatin architecture and noncoding RNAs are emerging as major players in both gene regulation and  stem cell differentiation. This conference will cover some of the most recent advances and cutting edge research in the field of chromatin organization\, transcription regulation and stem cell biology. We aim to provide a forum in which interdisciplinary discussions will promote cross-collaboration between experts in these areas. Moreover\, during the meeting\, there will be great opportunities for young scientists to meet the experts in the field.
URL:https://ces.b2sg.org/event/abcam-stem-cell-and-higher-order-chromatin-structure-conference/
LOCATION:Taormina Palazzo dei Congressi\, Sicily\, Italy
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20161101
DTEND;VALUE=DATE:20161105
DTSTAMP:20160426T185017Z
CREATED:20160426T184918Z
LAST-MODIFIED:20160426T185017Z
UID:15333-1477958400-1478303999@ces.b2sg.org
SUMMARY:Wellcome Genome Campus: Epigenomics of Common Diseases 2016
DESCRIPTION:The 6th Epigenomics of Common Diseases conference will bring together leading scientists from the fields of epigenomics\, genetics and bioinformatics to discuss the latest developments in this fast-moving area. \nEpigenetic variation plays an important role in disease processes and provides a promising focus for disease prediction\, prevention and treatment. Technological advancements in the past few years have fuelled a dramatic increase in the scale\, breadth and availability of epigenomic reference data. In addition\, novel developments such as single cell analysis and gene editing present exciting new opportunities. Associations between epigenetic variation\, a variety of risk factors and the development of many diseases continue to emerge but causality has\, in many instances\, not yet been established. \nThis meeting will focus on epigenomic studies across of a wide range of common and other diseases including cancer\, and will include approaches from a variety of different disciplines. It will explore technological and methodological developments and provide a forum to present and discuss recent advances in epigenomics of relevance to human disease.
URL:https://ces.b2sg.org/event/wellcome-genome-campus-epigenomics-of-common-diseases-2016/
LOCATION:Wellcome Genome Campus\, Hinxton\, Camebridge\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/Wellcome-Genome-Campus.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20161019
DTEND;VALUE=DATE:20161022
DTSTAMP:20160426T200648Z
CREATED:20160426T200648Z
LAST-MODIFIED:20160426T200648Z
UID:15345-1476835200-1477094399@ces.b2sg.org
SUMMARY:Chromatin\, Replication and Chromosomal Stability 2016
DESCRIPTION:The fourth meeting in the Chromatin Replication series will explore new ideas on the interplay between chromosome organization\, epigenetic inheritance and genome duplication.\n \nTopics \n\n\n\n\n\n\n\n\n\n\n\n\n\n​Mechanisms of DNA replication\nHow to replicate chromosomes\nCell division and epigenetic plasticity\nEpigenome inheritance and reprogramming\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe epigenetic framework guides events like replication\, repair and transcription\, which in turn themselves leave an imprint on chromatin and chromosomal structure. Understanding how modulation of chromatin during replication and repair influence cell fate decisions in normal development and disease represents a major challenge. By bringing together leading scientists in chromatin\, replication\, and epigenetics\, this conference aims to inspire discussions and new ideas on the interplay between chromosome organisation\, epigenetic inheritance and genome duplication.
URL:https://ces.b2sg.org/event/chromatin-replication-and-chromosomal-stability-2016/
LOCATION:University of Copenhagen\, Denmark
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20161005
DTEND;VALUE=DATE:20161009
DTSTAMP:20160625T123750Z
CREATED:20151230T051822Z
LAST-MODIFIED:20160625T123750Z
UID:12207-1475625600-1475971199@ces.b2sg.org
SUMMARY:Danube Scientific Conference on Epigenetics
DESCRIPTION:In the last couple of years the word epigenetics became used in several meanings. \nThis meeting will try to review the concepts of epigenetics\, the current state of the research in this field and the research methods of the field. Beside this we plan to be a meeting forum for the researchers and clinicians who are studying or planning to study topics in the field of epigenetics. \nWe plan to put forward those topics that deal mainly with the covalent modifications of the chromatin (DNA methylation and histone tail modifications) and their consequences especially those that define the transcriptional possibilities of a cell in a specific chromatin context. \nPlease join us at the meeting! We encourage everybody to submit an abstract. The results can be presented on posters or by talks\, most of which will be selected from the submitted abstracts.
URL:https://ces.b2sg.org/event/danube-scientific-conference-on-epigenetics/
LOCATION:Unnamed Venue\, Dudapest\, Hungary
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/Danube-Scientific-Conference-on-Epigenetics.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160926
DTEND;VALUE=DATE:20160927
DTSTAMP:20160426T215402Z
CREATED:20160426T194422Z
LAST-MODIFIED:20160426T215402Z
UID:15340-1474848000-1474934399@ces.b2sg.org
SUMMARY:abcam: Boston Chromatin Snapshot Series
DESCRIPTION:This event will be free of charge for all attendees but early registration is required. Space is limited so early registration is recommended. Registration will close 1 September 2016.\nEpigenetics and Chromatin are playing fundamental roles in the development of organisms as well as the development of pathologies\, such as cancer. This series of meetings will aim to bring together both the scientists studying the fundamentals of chromatin and epigenetics\, and those scientists studying specific systems or diseases that chromatin dynamics could be impacting. We hope that this journal club will inspire dialog\, lots of questions\, future collaborations\, and most of all\, energetic exchange. The meeting will have at least two keynote speakers and a selection of talks from trainees (e.g.\, graduate students and postdoctoral fellows).
URL:https://ces.b2sg.org/event/abcam-boston-chromatin-snapshot-series/
LOCATION:Joseph B. Martin Conference Center\, 77 Avenue Louis Pasteur\, Boston\, MA\,  02115\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160919
DTEND;VALUE=DATE:20160923
DTSTAMP:20160426T185859Z
CREATED:20160426T185520Z
LAST-MODIFIED:20160426T185859Z
UID:15334-1474243200-1474588799@ces.b2sg.org
SUMMARY:Wellcome Genome Campus: Genome Informatics conference
DESCRIPTION:This 16th Genome Informatics conference will focus on large-scale approaches to understanding the structure and biology of genomes. Biology is an experimental science that is experiencing an explosion of new data. This requires biologists to increase the scale and sophistication of the information technology used for their research. \nThe conference scope encompasses a wide range of methods for the analysis of these data\, including a focus on technologies such as variant-calling\, transcriptomic analysis\, and variant interpretation\, applied to very large genomic data sets. This meeting alternates between Hinxton\, UK and Cold Spring Harbor\, New York.
URL:https://ces.b2sg.org/event/wellcome-genome-campus-advanced-courses-and-scientific-conferences-genome-informatics-2016/
LOCATION:Wellcome Genome Campus\, Hinxton\, Camebridge\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/Wellcome-Genome-Campus.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160914
DTEND;VALUE=DATE:20160917
DTSTAMP:20160426T184342Z
CREATED:20160426T183029Z
LAST-MODIFIED:20160426T184342Z
UID:15328-1473811200-1474070399@ces.b2sg.org
SUMMARY:Wellcome Genome Campus: Single Cell Genomics 2016
DESCRIPTION:Building on the success of previous single cell genomics meetings\, this year’s meeting will be held at the Wellcome Genome Campus\, Hinxton\, UK. \n\n\n\nSingle cell genomics is rapidly emerging as a revolutionary technology transforming many fields of biological research\, including immunology and cancer. Through its many applications (e.g. single cell genome sequencing\, single cell transcriptomics\, and various single cell epigenetic profiling approaches)\, researchers can characterize the genetic and functional properties of individual cells in their native conditions\, leading to numerous experimental and clinical opportunities. \nAs technology is developing\, many critical questions are arising: \n\nWhich technologies are going to set the standard in the field?\nHow many cells needed to be sampled? How should sampling be designed and optimized?\nHow can the behaviour of groups of hundreds or thousands of single cells be analysed and modelled?\nWhat is the importance of modelling when precise single-cell-states are available?\nHow can single cell genomics and epigenomics be integrated?\nWhat are the immediate implications for immunology\, cancer research and germ cells?\n\nThese questions will be the focus of discussions at this year’s meeting. This conference will bring together biologists\,  methods developers\, computational modellers and genomics researchers interested in understanding biological variation at the single cell level.
URL:https://ces.b2sg.org/event/wellcome-genome-campus-single-cell-genomics-2016/
LOCATION:Wellcome Genome Campus\, Hinxton\, Camebridge\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/Wellcome-Genome-Campus.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160913
DTEND;VALUE=DATE:20160918
DTSTAMP:20160105T222345Z
CREATED:20151230T051245Z
LAST-MODIFIED:20160105T222345Z
UID:12204-1473724800-1474156799@ces.b2sg.org
SUMMARY:Epigenetics and Chromatin
DESCRIPTION:You are cordially invited to participate in the third Cold Spring Harbor Laboratory meeting on Epigenetics & Chromatin. The opening session will begin at 7:30 pm on Tuesday\, September 13 and the meeting will end after lunch on Saturday\, September 17\, 2016. As currently planned\, the program will have eight sessions devoted to oral presentations\, together with three poster sessions for presentations which cannot be accommodated in the formal sessions. Selection of talks for the oral sessions will be made by the organizers in conjunction with the session chairpersons\, from the submitted abstracts.
URL:https://ces.b2sg.org/event/epigenetics-and-chromatin/
LOCATION:Unnamed Venue\, Cold Spring Harbor\, NY\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/CSH.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160908
DTEND;VALUE=DATE:20160910
DTSTAMP:20160807T150339Z
CREATED:20160625T122255Z
LAST-MODIFIED:20160807T150339Z
UID:16199-1473292800-1473465599@ces.b2sg.org
SUMMARY:2nd Annual Epigenetics Discovery Congress
DESCRIPTION:The 2nd Annual Epigenetics Discovery Congress taking place on 8-9 September\, 2016 in London – UK will gather researchers\, academics and industry professionals working in epigenetic research to avail an opportunity to explore the potential of epigenetics. The congress will contribute towards novel and existing therapeutics\, current progress and trends in the inclusion of epigenetics in drug discovery and development. \nThe Cancer Epigenetics Society is a Supporting Association for this meeting\, and our members are eligible for a 40% discount on registration fees. Please contact the Cancer Epigenetics Society at info@ces.b2sg.org to claim the discount.
URL:https://ces.b2sg.org/event/2nd-annual-epigenetics-discovery-congress/
LOCATION:London Heathrow Marriot Hotel\,  Bath Road \, Heathrow Airport Hayes\, UB3 5AN\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/06/Epi_2016.jpg
ORGANIZER;CN="MnM Conferences":MAILTO:ajay.nimbalkar@mnmconferences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160908
DTEND;VALUE=DATE:20160910
DTSTAMP:20160426T194524Z
CREATED:20160426T182437Z
LAST-MODIFIED:20160426T194524Z
UID:15324-1473292800-1473465599@ces.b2sg.org
SUMMARY:abcam: RNA modifications and epitranscriptomics conference
DESCRIPTION:The meeting is aimed at bringing in students and postdocs as well as faculty involved in RNA modification and epitranscriptome research.  In addition to talks\, there will be a poster session and reception.\n \n\n\n\n\n\n\n\n\n\n\n\n\nTopics \n\nM6A mRNA methylation\nBiological functions of m6A RNA methylation\nDynamic RNA modifications\n​
URL:https://ces.b2sg.org/event/abcam-rna-modifications-and-epitranscriptomics-conference/
LOCATION:University of Chicago\, 5801 S Ellis Ave\, Chicago\, IL\, 60637\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160831
DTEND;VALUE=DATE:20160901
DTSTAMP:20160419T161802Z
CREATED:20160419T020949Z
LAST-MODIFIED:20160419T161802Z
UID:14924-1472601600-1472687999@ces.b2sg.org
SUMMARY:Translationale Onkologie (Translational Oncology)
DESCRIPTION:With the goal of further supporting collaborative translational cancer research projects at ‘Interdisciplinary Oncology Centers of Excellence’ and Comprehensive Cancer Centers\, the German Cancer Aid has decided to launch a third call for applications within the funding program ‘Translational Oncology’. Projects may be collaborative scientific projects (‘Verbundprojekte’) or innovative clinical trials\, which must be performed at more than two sites and necessitate close collaboration between several research groups. \nDuration of funding: – \nCoverd costs:  €7.000.000 annually \nNationality: At least one research group must be located at an ‘Interdisciplinary Oncology Center of Excellence’ funded by the German Cancer Aid.
URL:https://ces.b2sg.org/event/translationale-onkologie/
LOCATION:KY
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/deutsche-Krebshilfe.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160827
DTEND;VALUE=DATE:20160831
DTSTAMP:20160802T022230Z
CREATED:20160426T181215Z
LAST-MODIFIED:20160802T022230Z
UID:15320-1472256000-1472601599@ces.b2sg.org
SUMMARY:EMBL Conference: Transcription and Chromatin
DESCRIPTION:The EMBL Transcription and Chromatin meeting has a long-standing tradition in shaping the field of transcriptional regulation. The meeting brings together leading experts covering all aspects of transcription from cis-regulatory function\, long range regulation\, 3-dimensional looping\, the basal transcriptional machinery\, RNA polymerase regulation and function\, nucleosome positioning\, chromatin modifications\, chromatin remodelling\, and epigenetic inheritance of transcriptional silencing. The meeting contains many talks selected from the abstracts that are interspersed with invited speakers\, discussing the latest breakthroughs in transcriptional regulation. \n\n\n\n\n\n\nAims\nThe conference is designed to promote interactive discussions at both the talks and poster sessions. Given the excellent line up of speakers and the meeting’s outstanding reputation\, this is a ‘must’ attend for anyone interested in cutting edge research in transcription. \nTopics\n\nActivators\, enhancer function\, evolution and modelling\nLong range transcriptional regulation and enhancers\nGeneral basal transcriptional machinery\nPol II function\, pausing and the role of RNA in transcription\nChromatin modifications and transcription\nTranscriptional regulation during cell fate decisions – stem cell reprogramming and normal embryonic development
URL:https://ces.b2sg.org/event/embl-conference-transcription-and-chromatin/
LOCATION:EMBL\, Heidelberg\, Germany
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/EMBL-logo--e1525286945880.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160728
DTEND;VALUE=DATE:20160901
DTSTAMP:20160802T011734Z
CREATED:20160728T154017Z
LAST-MODIFIED:20160802T011734Z
UID:16749-1469664000-1472687999@ces.b2sg.org
SUMMARY:Assistant or Associate Professor/Staff level in Pediatric Research
DESCRIPTION:The Pediatric Institute of the Cleveland Clinic invites applications for new faculty positions at the Assistant or Associate Professor/Staff level. Exceptional candidates at the Professor/Staff level will also be considered. The positions will be based in the Lerner Research Institute of the Cleveland Clinic with a primary focus on basic or translational research. \nApplicants should have a M.D.\, Ph.D.\, D.V.M. or equivalent degree with postdoctoral training and show exceptional promise for an independent career in academic science. The Pediatric Institute is seeking individuals with a special interest in basic cellular and molecular processes\, and/or translational studies. \nAreas of special interest include\, but are not limited to: \nLung \nKidney \nPediatric Care \nGastrointestinal \nObesity and Diabetes \nMicrobiology \nEpigenetics \nAutism \nMicrobiology \nEnvironmental sciences \nNanotechnology \nImmunology \nThe successful candidate is expected to establish an innovative\, extramurally funded research program. The new faculty member will join a collaborative\, interdisciplinary group of investigators. Interactions with excellent clinical programs are readily available and provide the potential to develop multi-disciplinary and translational research programs. The Lerner Research Institute has a strong tradition of collaborative research\, and offers established programs for pre- and post-doctoral M.D. and Ph.D. trainees. Outstanding facilities and generous start-up funds are available. Salary will be commensurate with academic credentials and experience. \nThe Cleveland Clinic embraces diversity. Women\, underrepresented minorities and people with disabilities are strongly encouraged to apply. \nAt Cleveland Clinic Children’s\, every child receives world-class care. At our main campus in the heart of Cleveland\, Ohio\, as well as at our community hospitals and Family Health Centers located throughout northern Ohio\, children and families receive compassionate care from nationally and internationally renowned pediatricians and pediatric sub-specialists. \nMore than 300 pediatric medical and surgical specialists staffing 429 inpatient beds and 43 outpatient clinics forming the Cleveland Clinic Children’s network\, providing over 650\,000 outpatient visits\, 17\,000 hospital admissions\, 10\,000 surgeries\, and accepting over 1\,400 hospital transfers per year. \nMore than 100 pediatric physicians are recognized annually as being among the “Best Doctors in America.” \nCleveland Clinic Children’s has consistently ranked among the “Best Children’s Hospitals” by U.S. News and World Report . \nOur pediatric neurology and neurosurgery program ranked as the best in Ohio and among the top programs in the United States. \nOur pediatric gastroenterology program ranks among the top 10 programs in the United States according to U.S. News and World Report. \nCleveland Clinic is pleased to be an equal employment/affirmative action employer: Women/Minorities/Veterans/Individuals with Disabilities. \nSmoke/drug free environment. \n\n\n 
URL:https://ces.b2sg.org/event/assistant-or-associate-professorstaff-level-in-pediatric-research/
LOCATION:Cleveland Clinic\, 9620 Carnegie Ave\, Cleveland \, OH\, 44195\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/CCF-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160728
DTEND;VALUE=DATE:20160901
DTSTAMP:20160802T011421Z
CREATED:20160728T151656Z
LAST-MODIFIED:20160802T011421Z
UID:16744-1469664000-1472687999@ces.b2sg.org
SUMMARY:Post-Doctoral Research Fellow\, Cancer Genetics\Epigenetics
DESCRIPTION:Cures Start Here. At Fred Hutchinson Cancer Research Center\, home to three Nobel laureates\, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent\, diagnose and treat cancer\, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy\, which harnesses the power of the immune system to treat cancer. An independent\, nonprofit research institute based in Seattle\, Fred Hutch houses the nation’s first and largest cancer prevention research program\, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.  \nResponsibilities \nA postdoctoral position is available in the MacPherson Lab at Fred Hutchinson Cancer Research Center. The project will focus on small cell lung cancer (SCLC)\, a neuroendocrine tumor type that exhibits initial sensitivity to chemotherapy but invariable emergence of chemoresistance. Our lab is interested in linking specific gene mutations in SCLC to therapeutic vulnerabilities. We have developed a panel of new mouse models that can be used in this effort. With our clinical collaborators\, we are also generating patient derived xenograft models of SCLC. The project will be focused on chromatin regulators in SCLC and is particularly well suited to individuals with experience or interest in epigenetics/chromatin biology and cancer. In addition to in vivo studies\, the project will employ cell based screening to link specific SCLC-mutated genes to genetic vulnerabilities. The project will have a therapeutic component\, testing the efficacy and molecular mechanisms underlying new potential targeted therapy for SCLC. \nThe candidate will lead efforts to link SCLC gene mutations to therapeutic vulnerabilities\, combining in vivo studies with cell based screening and molecular analyses. The candidate should be able to drive an individual project but also be highly collaborative. \nQualifications \nWe are looking for a highly motivated individual with a PhD or MD and interests in cancer genetics\, mouse models\, epigenetics and therapeutics. A strong foundation in molecular and cell biology is essential. The candidate should be independent\, enthusiastic and scientifically rigorous.
URL:https://ces.b2sg.org/event/post-doctoral-research-fellow-cancer-geneticsepigenetics/
LOCATION:University of Miami\, 1320 S Dixie Hwy\, Coral Gables\, FL\, 33146\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/fred_hutch.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160728
DTEND;VALUE=DATE:20160901
DTSTAMP:20160728T135755Z
CREATED:20160728T135652Z
LAST-MODIFIED:20160728T135755Z
UID:16738-1469664000-1472687999@ces.b2sg.org
SUMMARY:Postdoctoral Scholar in Computational Biology and Epigenetics
DESCRIPTION:Postdoctoral Scholar position available for highly motivated candidates to join the Department of Emergency Medicine at Stanford University School of Medicine starting in September 2016 to investigate epigenetic regulation of innate immunity using high throughput epigenetic and molecular biology tools in order to discover and translate novel biomarkers for systemic infectious disease diagnosis and prognosis\, screen for targeted therapies\, and understand their underlying mechanisms of action in disease pathogenesis. \n Qualifications:\n• Ph.D. degree with in computational biology\, bioinformatics\, or immunology required.\n• Prior training or degree received from US/UK/Canadian academic institution required.\n• Knowledge and experience with various bioinformatic and biostatistical analysis tools are required.\n• Relevant prior hands-on experience in state-of-the-art methods such as Next Generation Sequencing (ChiP-Seq\, RNASeq\, etc.) and its data analysis\, array-based miRNA/gene expression analysis\, and non-coding RNA work will be given preference\n• Must possess excellent writing and communication skills\, a solid record of peer-reviewed publications\, commitment to drive scientific projects\, motivation for high impact\, high quality research\, ability to work closely with an interdisciplinary research team.\n• Applicants must be able to learn and develop new skills as required for the studies. Ability to work independently is expected. \nStanford University is an Equal Opportunity/Affirmative Action Employer. \nSalary commensurate with experience.\nTo apply for this position\, please send email to Dr. Samuel Yang at syang5@stanford.edu
URL:https://ces.b2sg.org/event/postdoctoral-scholar-in-computational-biology-and-epigenetics/
LOCATION:Stanford University\, School of Medicine\, 291 Campus Drive\, Stanford\, CA\, 94305\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/Stanford_School_of_Medicine.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160728
DTEND;VALUE=DATE:20160901
DTSTAMP:20160802T012105Z
CREATED:20160728T130258Z
LAST-MODIFIED:20160802T012105Z
UID:16737-1469664000-1472687999@ces.b2sg.org
SUMMARY:Postdoctoral Position in Stem Cell Biology and Cancer Epigenetics
DESCRIPTION:Job Description \nAn academic postdoctoral associate position is available in the laboratory of Dr. Jennifer Trowbridge to study epigenetic mechanisms governing hematopoietic stem cell lineage commitment\, and how deregulation of epigenetic modifications leads to myeloproliferative disorders including leukemia (http://trowbridgelab.com).\nThe Jackson Laboratory (JAX) offers a unique research and training environment characterized by multidisciplinary scientific collaboration\, unparalleled mouse resources\, outstanding core services\, and is located adjacent to Acadia National Park in coastal Maine. Translational research collaborations in genomics-based\, personalized medicine are fostered through our new JAX Genomic Medicine campus in Farmington\, CT. In addition to lab-based training\, JAX has developed a unique program for trainees to expand their professional skills in science communication\, entrepreneurship\, teaching\, mentoring and laboratory management to best prepare postdocs for future career opportunities. \nRequired Skills \nAbility to plan\, execute and analyze an independent research project as well as exceptional verbal and written communication skills. Preference given to self-motivated and career oriented individuals. \nRequired Experience \nA Ph.D. in biological or related sciences is required\, and a strong training background in molecular biology\, cell biology and/or epigenetics is preferred.\nApply by submitting a cover letter describing past research accomplishments\, research interests and career aspirations\, a current CV\, and the names of three references\, as one PDF file. \nAll qualified applicants will receive consideration for employment without regard to race\, color\, religion\, sex\, national origin\, disability or protected veteran status. \nJob Location: Bar Harbor\, Maine\, United States \nPosition Type: Full-Time/Regular \nSalary: 40\,000.00 – 60\,000.00 USD \n 
URL:https://ces.b2sg.org/event/postdoctoral-position-in-stem-cell-biology-and-cancer-epigenetics/
LOCATION:Jackson Laboratory\, 600 Main Street\, Bar Harbor\, ME\, 04609\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/Jackson-Lab.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160728
DTEND;VALUE=DATE:20160901
DTSTAMP:20160802T013332Z
CREATED:20160728T125712Z
LAST-MODIFIED:20160802T013332Z
UID:16736-1469664000-1472687999@ces.b2sg.org
SUMMARY:Postdoctoral Associate - Genome Technologies
DESCRIPTION:GENERAL SUMMARY \nThe Post-Doctoral Associate in Genome Technologies will develop molecular biology and sequencing applications to characterize the genome\, transcriptome\, & epigenetic changes as well as chromatin biology pertinent to disease conditions\, organismic response to environment changes and developmental cue. The research and developmental projects will be centered on sequencing based genome\, transcriptome and chromatin characterization. \n\nThe position will have a significant role in setting up novel\, cutting edge sequencing methods and platforms\, and will have the opportunity to work with various staff throughout The Jackson Laboratory. \n\n\nKEY RESPONSIBILITIES \n\nEvaluate the nature of the biological challenges and design molecular biological approaches\nPerform relevant experiments including the development and implementation of new sequencing or genomics methods to address critical biological questions\nParticipate in the development and implementation of wet lab protocols\nProvide technical and analytical interpretation of data\nImprove existing protocols & methods and implement new tools for general use\nMay also provide technical training and support to external collaborators\n\n\n\nREQUIRED SKILLS  \n\nAbility to drive projects and derive new ideas\nAbility to contribute publications and present data and analysis in scientific meetings\nMust recognize and understand the key challenges and opportunities in the field of genome technologies and sequencing applications surrounding areas critical to JAX’s core mission.\n\n  \n  \nMINIMUM QUALIFICATIONS \n\nPh.D. training in relevant area\n\n\nJob Location: Farmington\, Connecticut\, United States \nPosition Type: Full-Time/Regular \n 
URL:https://ces.b2sg.org/event/postdoctoral-associate-genome-technologies/
LOCATION:Jackson Laboratory\, 600 Main Street\, Bar Harbor\, ME\, 04609\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/Jackson-Lab.png
END:VEVENT
END:VCALENDAR